Martina Banyay

Part of T Blomqvist Holding AB, Stockholm Meeting Selection AB is a company that offers luxurious accommodations in 7 beautiful castles and hotels located only 30 minutes from Stockholm, SE. The Swedish company provides historic premises, high-quality food, beautiful environments, and scenic surroundings for its guests. The CEO of the company is Maria Norberg.

The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products.

Viedoc Technologies AB is a Swedish company that specializes in clinical data management solutions. The company is based in Uppsala, Sweden. The company's fully integrated document management system is highly secure and accessible 24/7. The core of their clinical trial solution consists of Viedoc Designer, Admin, and Clinic, which allows users to design, manage, and execute clinical studies from scratch. The company's goal is to help clinical research so that necessary treatments can reach people who need them faster. The company was founded in 2003 by Sverre Bengtsson and Henrik Blombergsson, and the CEO is Mats Klaar.

RegSmart Life Science AB is a Swedish company that offers strategic advice and support to clients in the life science industry. The private company is based in Uppsala, Sweden. The company specializes in helping clients fulfill post-approval pharmacovigilance requirements and navigate the complex regulatory landscape. The company's services include defining regulatory plans, assessing the need for clinical data, and providing strategic and operational support throughout the product lifecycle. The CEO of the company is Marie Gårdmark.

IP Enabler AB collaborates with leading digital therapeutics, digital care, medical device, and pharmaceutical companies to develop intellectual property rights (IPR) for combinations of pharmaceuticals and digital health technologies. The Swedish company's vision is to create a learning digital therapeutic that supports the usage of pharmaceuticals for improved efficacy and safety on patient conditions. IP Enabler's recently approved broad IPR assets cover a broad range of pharmaceuticals and digital therapeutics/digital care products, enabling opportunities for strengthened and prolonged IPR for combinations. The CEO of the company is Johan Cederlund.